US equities |
NVDA $181.60 ▼-9.26% MU $656.39 ▼-17.46% AMD $404.40 ▼-17.26% TSLA $343.69 ▼-10.77% AAPL $344.17 ▼-1.53% SNDK $806.43 ▼-22.26% MSFT $535.93 ▼-3.58% AMZN $260.21 ▼-2.19%
FinancialContent

BioVie Inc. - Common stock (NQ:BIVI)

1.210 -0.130 (-9.70%)
Delayed Quote Updated: 4:00 PM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioVie Inc. - Common stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
News headline image
Melco, Ardelyx And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Cosmos Health Inc. (NASDAQ: COSM) shares dipped 37.7% to $14.33 in... 
Via Benzinga
News headline image
In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Cuong Do, President & CEO BioVie Inc.
Via ACCESSWIRE
News headline image
EXCLUSIVE: Benzinga Moneymaker Series: Top 5 Stocks For Investors To Watch ↗
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information.... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Why BioVie Stock Is Soaring Today ↗
The more investors learned about BioVie's latest clinical results, the more they liked. 
Via The Motley Fool
News headline image
BioVie Highlights Encouraging NE3107 Data In Parkinson's, Alzheimer's Trials ↗
 
Via Benzinga
News headline image
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
US Stocks Mixed; Dow Rises 50 points ↗
U.S. stocks traded mixed this morning, with the Dow Jones gaining more than 50 points on Wednesday. 
Via Benzinga
News headline image
Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split. 
Via Benzinga
News headline image
Why BioVie's Shares Tumbled Tuesday ↗
The clinical-stage biotech released data on its prospective Alzheimer's therapy. 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC... 
Via Benzinga
News headline image
Why MEI Pharma Shares Are Trading Lower By Around 35%; Here Are 20 Stocks Moving Premarket ↗
Gainers Starry Group Holdings, Inc. (NYSE: STRY) shares rose 43.5% to $0.2011 in pre-market trading after dipping more than 20% on Monday. 
Via Benzinga
News headline image
Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Summit Therapeutics Inc. (NASDAQ: SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Good morning, trader! We're starting off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning! 
Via InvestorPlace
News headline image
How Is The Market Feeling About BioVie? ↗
BioVie's (NASDAQ:BIVI) short percent of float has fallen 5.22% since its last report. The company recently reported that it has 167 thousand shares sold short, which is 2.36% of all regular shares that... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 68 companies reached new 52-week highs. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  During Thursday's session, 108 stocks hit new 52-week highs. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  During Monday's session, 50 stocks hit new 52-week highs. 
Via Benzinga
News headline image
Alphabet To $136? Plus This Analyst Slashes PT On United Natural Foods ↗
Truist Securities cut the price target on Alphabet Inc. (NASDAQ: GOOGL) from $145 to $136. Truist Securities analyst Youssef Squali maintained a Buy rating on the stock. Alphabet shares rose 2.5% to... 
Via Benzinga
News headline image
Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket ↗
Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday. 
Via Benzinga
News headline image
BioVie Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
  
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Is Tandy Leather Factory (TLFA) Stock the Next Big Squeeze? ↗
Tandy Leather Factory (TLFA) stock is on the move Wednesday as investors react to the company uplisting its shares to the Nasdaq Exchange. 
Via InvestorPlace
News headline image
What Is Going on With Sidus Space (SIDU) Stock Today? ↗
Sidus Space (SIDU) stock is rising higher on Wednesday after the company announced an agreement with Elon Musk's SpaceX. 
Via InvestorPlace
News headline image
BioVie (BIVI) Stock Pops on Positive Alzheimer’s Trial Results ↗
The buying pressure is building with BIVI stock today as BioVie releases encouraging clinical trial results for a hard-to-treat ailment. 
Via InvestorPlace
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >